Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058392

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2058392

Non-Invasive Biosensor Market, By Technology, By Product Type, By End User, By Geography

PUBLISHED:
PAGES: 254 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Non-Invasive Biosensor Market is estimated to be valued at USD 7.5 Bn in 2026 and is expected to reach USD 16.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 7.5 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.50% 2033 Value Projection: USD 16.7 Bn

Non-invasive biosensors are novel diagnosis devices, which do not require any invasive procedure for detection of any substance or disease. This technology uses sweat, tears, or saliva for diagnostic purpose. Glucose monitoring and blood analytes monitor have become available in the market, which uses non-invasive biosensors. Moreover, there are many non-invasive biosensors under development and under clinical trial for new applications such as cancer and blood alcohol concentration detection.

Market Dynamics

Increasing approval and launches of novel non-invasive biosensors is expected to boost growth of global non-invasive biosensors market in the near future. For instance, in 2016, Nemaura Medical, Inc. received CE approval in the European Union for its latest sugarBEAT, a minimally invasive wireless continuous glucose monitor. Moreover, in 2013, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device. Increasing research and development activities for developing novel non-invasive biosensors is also expected to drive growth of market in the near future. For instance, in 2017, Mclean Hospital announced that LabPatch-alcohol, its non-invasive skin patch that detects blood alcohol concentration, is in clinical trial. LabPatch-alcohol is in early Phase 1 stage of clinical trial. Furthermore, increasing prevalence of diabetes is also expected to increase demand for non-invasive biosensors for diagnosis. According to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global non-invasive biosensors market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global non-invasive biosensors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-invasive biosensors market

Market Segmentation

  • By Technology (Revenue, USD Bn, 2021-2033)
    • Optical
    • Transdermal
    • Thermal
    • Others
  • By Product Type (Revenue, USD Bn, 2021-2033)
    • Glucose monitors
    • Blood Analytes Monitors
    • Breathalyzers
    • Others
  • By End User (Revenue, USD Bn, 2021-2033)
    • Homecare Settings
    • Hospitals
    • Diagnostic Lab
    • Others
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Nemaura Medical, Inc.
    • MediWise Ltd.
    • Integrity Applications Inc.,
    • OrSense
    • Medtronic Plc
    • GE Healthcare
    • Philips Healthcare
    • Akers Biosciences, Inc.
    • Abbott Laboratories.
Product Code: CMI1704

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Recent Product Approval/Launch
  • Pipeline Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • PEST Analysis
  • PORTER Analysis
  • Epidemiology

4. Global Non-Invasive Biosensors Market, By Technology, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Thermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

5. Global Non-Invasive Biosensors Market, By Product Type, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Glucose monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Blood Analytes Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Breathalyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

6. Global Non-Invasive Biosensors Market, By End User, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Diagnostic Lab
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

7. Global Non-Invasive Biosensors Market, By Region, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of APAC Japan
      • Australia
  • Middle East
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • Central Africa
      • South Africa
      • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Nemaura Medical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • MediWise Ltd.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Integrity Applications Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • OrSense
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic Plc
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GE Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Philips Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Akers Biosciences, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!